Monitoring the Secretory Behavior of the Rat Adrenal Medulla by High-Performance Liquid Chromatography-Based Catecholamine Assay from Slice Supernatants

Abstract

Catecholamine (CA) secretion from the adrenal medullary tissue is a key step of the adaptive response triggered by an organism to cope with stress. Whereas molecular and cellular secretory processes have been extensively studied at the single chromaffin cell level, data available for the whole gland level are much scarcer. We tackled this issue in rat by developing an easy to implement experimental strategy combining the adrenal acute slice supernatant collection with a high-performance liquid chromatography-based epinephrine and norepinephrine (NE) assay. This technique affords a convenient method for measuring basal and stimulated CA release from single acute slices, allowing thus to individually address the secretory function of the left and right glands. Our data point that the two glands are equally competent to secrete epinephrine and NE, exhibiting an equivalent epinephrine:NE ratio, both at rest and in response to a cholinergic stimulation. Nicotine is, however, more efficient than acetylcholine to evoke NE release. A pharmacological challenge with hexamethonium, an α3-containing nicotinic acetylcholine receptor antagonist, disclosed that epinephrine- and NE-secreting chromaffin cells distinctly expressed α3 nicotinic receptors, with a dominant contribution in NE cells. As such, beyond the novelty of CA assays from acute slice supernatants, our study contributes at refining the secretory behavior of the rat adrenal medullary tissue, and opens new perspectives for monitoring the release of other hormones and transmitters, especially those involved in the stress response.

Effects of humeral intraosseous epinephrine in a pediatric hypovolemic cardiac arrest porcine model

“…These samples were placed on dry ice and then shipped to the University of Washington’s Pharmacokinetic Laboratory for epinephrine assays. Epinephrine concentrations in plasma were determined using HPLC with tandem mass spectrometry as previously described in the literature and is considered a routinely used method for epinephrine assays in plasma 29…”

From organotypic culture to body‐on‐a‐chip: A neuroendocrine perspective

“…86,87 Independently, another group used tissue culture supernatants collected from 150-μm thick adrenal slices to measure changes in catecholamine secretion using high-performance liquid chromatography in response to acetylcholine, nicotine and hexamethonium. 88 This study did not provide temporal resolu-…”

Nicotine and vascular dysfunction

“…The cardiovascular effects of central α7‐ and α4β2‐nAChR activation have also been shown to involve the release of vasopressin 13 . On peripheral postganglionic sympathetic nerve endings including the adrenal medulla, nicotine stimulation of nAChR results in catecholamine release, more potently than ACh 14 . Because an increase in cytosolic calcium is a prerequisite for chromaffin cell exocytosis, 15 it is likely that α7, α9, and/or α9/α10 nAChR activation would trigger instructive signalling cascades contributing to catecholamine release from these cells 14 …”

“…medulla, nicotine stimulation of nAChR results in catecholamine release, more potently than ACh. 14 Because an increase in cytosolic calcium is a prerequisite for chromaffin cell exocytosis, 15 it is likely that α7, α9, and/or α9/α10 nAChR activation would trigger instructive signalling cascades contributing to catecholamine release from these cells. 14 The effects of nicotine on long-term BP control are controversial.…”